EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Paeonol alleviates neuropathic pain by modulating microglial M1 and M2 polarization via the RhoA / p38MAPK signaling pathway

Xin Li iD, Huimei Shi, Di Zhang iD, Bei Jing, Zhenni Chen, Yachun Zheng, Shiquan Chang, Li Gao, Guoping Zhao

CNS Neuroscience & Therapeutics · 2023-09 · 29 (9) · 2666-2679

DOI: 10.1111/cns.14211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 10.04.2023. Verfasst von Xin Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Jinan University, Guangzhou, China. Hauptthemen laut MEDLINE: Microglia, Neuralgia. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to investigate the potential mechanism of paeonol in the treatment of neuropathic pain.

Methods

Relevant mechanisms were explored through microglial pseudotime analysis and the use of specific inhibitors in cell experiments. In animal experiments, 32 SD rats were randomly divided into the sham operation group, the chronic constrictive injury (CCI) group, the ibuprofen group, and the paeonol group. We performed behavioral testing, ELISA, PCR, Western blotting, immunohistochemistry, and immunofluorescence analysis.

Results

The pseudotime analysis of microglia found that RhoA, Rock1, and p38MAPK were highly expressed in activated microglia, and the expression patterns of these genes were consistent with the expression trends of the M1 markers CD32 and CD86. Paeonol decreased the levels of M1 markers (IL1β, iNOS, CD32, IL6) and increased the levels of M2 markers (IL10, CD206, ARG‐1) in LPS‐induced microglia. The expression of iNOS, IL1β, RhoA, and Rock1 was significantly increased in LPS‐treated microglia, while paeonol decreased the expression of these proteins. Thermal hyperalgesia occurred after CCI surgery, and paeonol provided relief. In addition, paeonol decreased the levels of IL1β and IL8 and increased the levels of IL4 and TGF‐β in the serum of CCI rats. Paeonol decreased expression levels of M1 markers and increased expression levels of M2 markers in the spinal cord. Paeonol decreased IBA‐1, IL1β, RhoA, RhoA‐GTP, COX2, Rock1, and p‐p38MAPK levels in the spinal dorsal horn.

Conclusion

Paeonol relieves neuropathic pain by modulating microglial M1 and M2 phenotypes through the RhoA/p38 MAPK pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaNeuralgiaRatsAnimalsRats, Sprague-DawleyLipopolysaccharidesMAP Kinase Signaling SystemSpinal Cord Dorsal HornAcetophenones

Stichwörter der Autor:innen

CCIPaeonolPseudotimeRhoAp38MAPKsingle-cell sequencing

Substanzen

LipopolysaccharidespaeonolAcetophenones

Autor:innen und Institutionen

  • College of Traditional Chinese Medicine, Jinan University, Guangzhou, China.

ORCID-Profile: Xin Li, Di Zhang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, X., Shi, H., Zhang, D., Jing, B., Chen, Z., Zheng, Y., Chang, S., Gao, L., & Zhao, G. (2023). Paeonol alleviates neuropathic pain by modulating microglial M1 and M2 polarization via the RhoA / p38MAPK signaling pathway. CNS Neuroscience & Therapeutics, 29(9), 2666-2679. https://doi.org/10.1111/cns.14211

Vancouver

Li X, Shi H, Zhang D, Jing B, Chen Z, Zheng Y, et al. Paeonol alleviates neuropathic pain by modulating microglial M1 and M2 polarization via the RhoA / p38MAPK signaling pathway. CNS Neuroscience & Therapeutics. 2023;29(9):2666-2679. doi:10.1111/cns.14211

BibTeX
@article{Li2023,
  author = {Li, Xin and Shi, Huimei and Zhang, Di and Jing, Bei and Chen, Zhenni and Zheng, Yachun and Chang, Shiquan and Gao, Li and Zhao, Guoping},
  title = {Paeonol alleviates neuropathic pain by modulating microglial M1 and M2 polarization via the RhoA / p38MAPK signaling pathway},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2023},
  volume = {29},
  number = {9},
  pages = {2666--2679},
  doi = {10.1111/cns.14211}
}
Kostenlos starten →